1-Methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 250mg

2,6-Bis((S)-4-(tert-butyl)-4,5-dihydrooxazol-2-yl)pyridine, 95.0%, 1g

Hexamethylbenzene, 98.0%, 5g

(R)-(+)-2-Benzyloxypropionic acid, 98%, 100mg

diethyl (4-amino-1H-indol-6-yl)phosphonate, 95.0%, 250mg

(2S,4S)-4-Fluoropyrrolidine-2-carbonitrile hydrochloride, 98%, 250mg

3-(Benzyloxy)-6-bromo-2-fluorophenol, 95.0%, 5g

1,1'-(1H-Indole-1,3-diyl)diethanone, 95.0%, 25g

4-METHYL-N-(3-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)PIPERIDINE-1-CARBOXAMIDE, 95%, 250mg

tert-Butyl 4-(2-chloro-4-fluorobenzylamino)piperidine-1-carboxylate, 1g

Fleroxacin>98.0%(T)(HPLC)5g

TISAB solution II, for fluoride determination, 1 l, plastic packaging.

2-Bromo-5-fluoro-4-methoxyaniline, 97%, 250mg